A detailed history of Mendel Capital Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Mendel Capital Management LLC holds 1,031 shares of LLY stock, worth $933,446. This represents 0.53% of its overall portfolio holdings.

Number of Shares
1,031
Previous 1,031 -0.0%
Holding current value
$933,446
Previous $600,000 33.67%
% of portfolio
0.53%
Previous 0.43%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 26, 2024

BUY
$525.19 - $619.13 $16,280 - $19,193
31 Added 3.1%
1,031 $600,000
Q4 2021

Feb 16, 2022

BUY
$224.85 - $279.04 $224,850 - $279,040
1,000 New
1,000 $276,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $860B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Mendel Capital Management LLC Portfolio

Follow Mendel Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mendel Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mendel Capital Management LLC with notifications on news.